NM_001014763.1(ETFB):c.278dupC (p.Pro94Thrfs) AND not specified

Clinical significance:Benign (Last evaluated: Mar 1, 2018)

Review status:2 stars out of maximum of 4 stars

criteria provided, multiple submitters, no conflicts

Based on:
2 submissions [Details]
Record status:
current
Accession:
RCV000185872.2

Allele description [Variation Report for NM_001014763.1(ETFB):c.278dupC (p.Pro94Thrfs)]

NM_001014763.1(ETFB):c.278dupC (p.Pro94Thrfs)

Gene:
ETFB:electron transfer flavoprotein subunit beta [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
19q13.41
Genomic location:
Preferred name:
NM_001014763.1(ETFB):c.278dupC (p.Pro94Thrfs)
HGVS:
  • NC_000019.10:g.51354361dupG
  • NG_007115.1:g.17058dup
  • NM_001014763.1:c.278dupC
  • NM_001985.2:c.58-53dupC
  • NP_001014763.1:p.Pro94Thrfs
  • NC_000019.9:g.51857614_51857615insG
  • NC_000019.9:g.51857615dupG
  • NM_001985.2:c.58-53_58-52insC
  • p.P94TfsX8
Links:
dbSNP: rs74357706
NCBI 1000 Genomes Browser:
rs74357706
Molecular consequence:
  • NM_001014763.1:c.278dupC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001985.2:c.58-53dupC - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000238824GeneDxcriteria provided, single submitter
Benign
(Mar 1, 2018)
germlineclinical testing

Citation Link,

SCV000539117Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicinecriteria provided, single submitter
Benign
(Mar 28, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From GeneDx, SCV000238824.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine, SCV000539117.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 406/12518=3.24%

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 30, 2019

Support Center